Recognizing Adolescent Depression with Parent- and Youth-Report Screens in Pediatric Primary Care.


Journal

The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410

Informations de publication

Date de publication:
06 2021
Historique:
received: 04 11 2020
revised: 12 01 2021
accepted: 28 01 2021
pubmed: 7 2 2021
medline: 25 8 2021
entrez: 6 2 2021
Statut: ppublish

Résumé

To compare the use of the parent-report Pediatric Symptom Checklist (PSC-17P) and youth-report Patient Health Questionnaire-9 Modified for Teens (PHQ-9M) in compliance with recent quality standards for adolescent depression screening. Parents of 5411 pediatric outpatients (11.0-17.9 years old) completed the PSC-17P, which contains scales that assign categorical risk for overall (PSC-17P-OVR), internalizing (PSC-17P-INT), externalizing (PSC-17P-EXT), and attention (PSC-17P-ATT) problems. Adolescents completed the PHQ-9M, which assesses depressive symptoms. Both forms were completed online within 24 hours of each other before pediatric well-child visits. A total of 9.9% of patients (n = 535) were at risk on the PSC-17P-OVR, 14.3% (n = 775) were at risk on the PSC-17P-INT, and 17.0% (n = 992) were at risk on either or both scales (PSC-17P-OVR and/or PSC-17P-INT). Using the PHQ-9M cut-off score of 10 (moderate-very severe depression), an additional 2.4% (n = 131) were classified as at risk, with 66.8% (n = 263) of all PHQ-9M positives (n = 394) also coded as at risk by the PSC-17P-OVR and/or PSC-17P-INT scales. Using a PHQ-9M cut-off score of 15 (severe-very severe depression), only 29 patients (21.8% of the PHQ-9M positives) not identified by the PSC-17P-OVR and/or PSC-17P-INT were classified as being at risk. The combined PSC-17P-OVR and/or PSC-17P-INT scales identified 17% of adolescents as at risk for depression, including about two-thirds to three-quarters of adolescents classified as at risk on the PHQ-9M. These findings support using the PSC-17P to meet quality standards for depression as well as overall screening in pediatrics. Primary care clinicians can add the PHQ-9M to identify additional adolescents who may self-report depressive symptoms.

Identifiants

pubmed: 33548264
pii: S0022-3476(21)00103-7
doi: 10.1016/j.jpeds.2021.01.069
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

220-226.e1

Subventions

Organisme : NIMH NIH HHS
ID : R44 MH116751
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Michael Jellinek (M)

Department of Psychiatry, Massachusetts General Hospital, Boston, MA; Department of Psychiatry, Harvard Medical School, Boston, MA; Department of Pediatrics, Harvard Medical School, Boston, MA.

Paul Bergmann (P)

Foresight Logic, Inc., Saint Paul, MN.

Juliana M Holcomb (JM)

Department of Psychiatry, Massachusetts General Hospital, Boston, MA.

Alexa Riobueno-Naylor (A)

Department of Counseling, Developmental, and Educational Psychology, Lynch School of Education and Human Development, Boston College, Boston, MA.

Anamika Dutta (A)

Department of Psychiatry, Massachusetts General Hospital, Boston, MA.

Haregnesh Haile (H)

Department of Psychology, The Catholic University of America, Washington, DC.

Raymond Sturner (R)

Department of Pediatrics, The John Hopkins University School of Medicine, Baltimore, MD; Center for Promotion of Child Development through Primary Care, Baltimore, MD.

Barbara Howard (B)

Department of Pediatrics, The John Hopkins University School of Medicine, Baltimore, MD; Total Child Health, Baltimore, MD.

J Michael Murphy (JM)

Department of Psychiatry, Massachusetts General Hospital, Boston, MA; Department of Psychiatry, Harvard Medical School, Boston, MA. Electronic address: mmurphy6@partners.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH